United States: FDA Announces Import Staffing Change At International Mail Facilities

Earlier this month, The Washington Post reported that Food and Drug Administration (FDA) Commissioner Scott Gottlieb announced that he was reallocating three dozen employees to international mail facilities (IMF), as well as the FDA'scybercrime and forensic chemistry units, to focus on suspicious shipments that may contain illegal food and medical products.1 Commissioner Gottlieb indicated that the deployment will be funded through existing FDA resources, but he did not indicate how the deployment will affect the processing of imports at express consignment carrier facilities or other ports of entry. 

The initiative is the first major announcement by the new FDA Commissioner on FDA import enforcement. It shows that Commissioner Gottlieb is aware of the sharp and continuing increase in the volume of imports that the FDA oversees, but it also demonstrates the trade-offs and challenges that the FDA faces in dealing with this volume.

The number of imports that the FDA has overseen has increased from 15 million shipments in fiscal year (FY) 2006 to 36.9 million shipments in FY 2016. Currently, 40 percent of listed finished drugs, 35 percent of medical devices, 50 percent of fresh fruit and 80 percent of seafood on the U.S. market are imported foreign goods. Working with U.S. Customs and Border Protection (CBP) and others, the FDA screens imports at ports of entry (such as seaports, land border crossings and airports), IMFs (where international packages sent through the U.S. Postal Service are screened) and express courier hubs (where packages sent through private courier services are screened). The volume in all of these facilities has increased significantly over the past decade. In order to identify potentially illegal imports, the FDA uses portable screening devices to examine suspicious items and then sends many to its Forensic Chemistry Center for further analysis and refers some to its Office of Criminal Investigation.

The FDA's announcement focuses exclusively on identifying illegal imports through a specific facility–IMF. IMFs have recently been the focus of drug interdiction programs, since postal shipments are not subject to the same rigorous reporting and screening requirements as shipments entering through traditional ports of entry or express courier hubs. Furthermore, FDA inspectors also have limited authority to open and inspect postal packages, as opposed to packages imported by private express consignment carriers. 

Given the potentially limited impact of the personnel shift, the announcement raises the question of the staffing and resourcing of FDA operations at ports and courier hubs for the screening of legal products. Commissioner Gottlieb states that he is redeploying existing resources to IMFs. The work of the FDA's import personnel is a specialty, which limits the FDA's ability to shift existing personnel from outside the import field to import operations. For example, the FDA could not easily redeploy someone who conducts inspections of drug manufacturing facilities to an IMF. Without a funding increase and changes to the reporting requirements for postal shipments, an emphasis on IMFs may place pressure on staffing resources at ports and courier hubs, which have personnel with the skills to work at IMFs. 

In the past, the FDA has used several means to grapple with the pressure caused by the growing volume of imports. 

First, it has sought and used new statutory tools and additional funding. For example, with administration support, Congress passed the FDA Food Safety and Modernization Act (FSMA) in 2011. The FDA used authority under FSMA to create a Voluntary Qualified Importer Program (VQIP), which expedites FDA review for food importers who have a strong food-safety record.  VQIP is analogous to Global Entry's expedited screening process for trusted travelers. The FDA also received additional appropriations from Congress to implement FSMA's import provisions. Outside of food, the FDA has launched a Secure Supply Chain Pilot Program for drugs and is in the process of working with the CBP to develop a trusted trader program. The FDA announced the latter effort in 2014.     

Second, the FDA has used information technology to focus its resources on higher-risk products and to become more efficient. It has increased the use of the Predictive Risk-based Evaluation for Dynamic Compliance Targeting ("PREDICT") system to expedite screening of lower-risk imports. Last year, the CBP worked with the FDA and other agencies to implement the Automated Commercial Environment/International Trade Data System, which created a single portal through which importers could submit data.

Even with these steps, the increase in volume has far exceeded the resources devoted to screening imports.

Commissioner Gottlieb's announcement shows that the FDA continues to adjust its priorities for the screening and enforcement of imports that it regulates. As the FDA increases resources at IMFs, it may take steps, such as expanding its use of trusted importer programs like VQIP, further refining how it identifies high-risk products and seeking additional resources. Some of these steps might call for public comment. Industry should remain aware of this ever-changing environment and of the need to ensure that increasing volume does not delay shipments of FDA-regulated commerce. Industry should provide input as the FDA considers new programs.


1. See https://www.washingtonpost.com/news/to-your-health/wp/2017/08/04/fda-to-step-up-fentanyl-targeting-at-postal-facilities/?utm_term=.ce3919fe29b6#comments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions